Clinical diagnostic focus Response Genetics operates a CLIA-certified clinical laboratory delivering molecular diagnostic testing services for cancer, highlighting opportunities to upsell additional tumor-specific genetic testing and companion diagnostic services to oncologists and pathologists.

Paraffin-based testing Expertise in extracting and analyzing genetic information from formalin-fixed, paraffin-embedded (FFPE) tumor samples positions the company to engage clinics and hospitals with legacy tissue archives seeking actionable molecular insights.

Mid-market traction With revenue in the low tens of millions and a small to mid-size employee base, there is potential to scale through targeted community hospital networks and regional cancer centers that require reliable, cost-effective molecular testing as they expand cancer care programs.

Growth opportunities Explore partnerships or channel programs with oncology practices, pathology groups, and reference labs to broaden test menu, expand payer coverage discussions, and increase volume through integrated testing workflows.